Skip to main content
Erschienen in: Journal of Nuclear Cardiology 4/2021

24.10.2019 | Editorial

Do we need dedicated cardiac SPECT systems?

verfasst von: Piotr Slomka

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Excerpt

Dedicated cardiac SPECT scanners have significantly improved in recent years,1 reducing imaging time and radiation dose. In particular, cardiac scanners have entered clinical practice,2,3 which use solid-state Cadmium-Zinc-Telluride (CZT) crystal detectors and feature innovative gantry designs, focusing on the heart. These new systems allow improvement in photon sensitivity (5-8 times higher) 4,5 for cardiac imaging, as well as image resolution (up to 2 times higher).5 While solid-state CZT detectors are more expensive than traditional NaI(Tl) crystal detectors with photomultipliers, they do have important imaging advantages. The CZT detectors have improved energy response, which significantly reduces the scatter component of measured data. They also offer superior intrinsic spatial resolution compared to conventional Anger cameras. The use of less-bulky detectors (no need for photomultipliers) has resulted in more compact scanner size which has facilitated small-footprint dedicated cardiac camera designs with custom imaging geometries and high-sensitivity collimation. There is a growing evidence, including large multicenter studies, that these solid-state SPECT systems demonstrate excellent diagnostic and prognostic utility in cardiac imaging.68
Literatur
1.
Zurück zum Zitat Slomka PJ, Patton JA, Berman DS, Germano G. Advances in technical aspects of myocardial perfusion SPECT imaging. J Nucl Cardiol 2009;16:255-76.CrossRef Slomka PJ, Patton JA, Berman DS, Germano G. Advances in technical aspects of myocardial perfusion SPECT imaging. J Nucl Cardiol 2009;16:255-76.CrossRef
2.
Zurück zum Zitat DePuey EG. Advances in SPECT camera software and hardware: Currently available and new on the horizon. J Nucl Cardiol 2012;19:551-81.CrossRef DePuey EG. Advances in SPECT camera software and hardware: Currently available and new on the horizon. J Nucl Cardiol 2012;19:551-81.CrossRef
3.
Zurück zum Zitat Slomka PJ, Dey D, Duvall WL, Henzlova MJ, Berman DS, Germano G. Advances in nuclear cardiac instrumentation with a view towards reduced radiation exposure. Curr Cardiol Rep 2012;14:208-16.CrossRef Slomka PJ, Dey D, Duvall WL, Henzlova MJ, Berman DS, Germano G. Advances in nuclear cardiac instrumentation with a view towards reduced radiation exposure. Curr Cardiol Rep 2012;14:208-16.CrossRef
4.
Zurück zum Zitat Sharir T, Ben-Haim S, Merzon K, Prochorov V, Dickman D, Ben-Haim S, et al. High-speed myocardial perfusion imaging: Initial clinical comparison with conventional dual detector anger camera imaging. JACC Cardiovasc Imaging 2008;1:156-63.CrossRef Sharir T, Ben-Haim S, Merzon K, Prochorov V, Dickman D, Ben-Haim S, et al. High-speed myocardial perfusion imaging: Initial clinical comparison with conventional dual detector anger camera imaging. JACC Cardiovasc Imaging 2008;1:156-63.CrossRef
5.
Zurück zum Zitat Imbert L, Poussier S, Franken PR, Songy B, Verger A, Morel O, et al. Compared performance of high-sensitivity cameras dedicated to myocardial perfusion SPECT: A comprehensive analysis of phantom and human images. J Nucl Med 2012;53:1897-903.CrossRef Imbert L, Poussier S, Franken PR, Songy B, Verger A, Morel O, et al. Compared performance of high-sensitivity cameras dedicated to myocardial perfusion SPECT: A comprehensive analysis of phantom and human images. J Nucl Med 2012;53:1897-903.CrossRef
7.
Zurück zum Zitat Betancur J, Commandeur F, Motlagh M, Sharir T, Einstein AJ, Bokhari S, et al. Deep learning for prediction of obstructive disease from fast myocardial perfusion SPECT: A multicenter study. JACC Cardiovasc Imaging 2018;11:1654-63.CrossRef Betancur J, Commandeur F, Motlagh M, Sharir T, Einstein AJ, Bokhari S, et al. Deep learning for prediction of obstructive disease from fast myocardial perfusion SPECT: A multicenter study. JACC Cardiovasc Imaging 2018;11:1654-63.CrossRef
8.
Zurück zum Zitat Betancur JA, Hu LH, Commandeur F, Sharir T, Einstein AJ, Fish MB, et al. Deep learning analysis of upright-supine high-efficiency SPECT myocardial perfusion imaging for prediction of obstructive coronary artery disease: A multicenter study. J Nucl Med 2018;60:664-70.CrossRef Betancur JA, Hu LH, Commandeur F, Sharir T, Einstein AJ, Fish MB, et al. Deep learning analysis of upright-supine high-efficiency SPECT myocardial perfusion imaging for prediction of obstructive coronary artery disease: A multicenter study. J Nucl Med 2018;60:664-70.CrossRef
9.
Zurück zum Zitat Keidar Z, Raysberg I, Lugassi R, Frenkel A, Israel O. Novel cadmium zinc telluride based detector general purpose gamma camera: Initial evaluation and comparison with a standard camera. J Nucl Med 2016;57:259. Keidar Z, Raysberg I, Lugassi R, Frenkel A, Israel O. Novel cadmium zinc telluride based detector general purpose gamma camera: Initial evaluation and comparison with a standard camera. J Nucl Med 2016;57:259.
10.
Zurück zum Zitat Goshen E, Beilin L, Stern E, Kenig T, Goldkorn R, Ben-Haim S. Feasibility study of a novel general purpose CZT-based digital SPECT camera: Initial clinical results. EJNMMI Phys 2018;5:6.CrossRef Goshen E, Beilin L, Stern E, Kenig T, Goldkorn R, Ben-Haim S. Feasibility study of a novel general purpose CZT-based digital SPECT camera: Initial clinical results. EJNMMI Phys 2018;5:6.CrossRef
11.
Zurück zum Zitat Fiechter M, Gebhard C, Fuchs TA, Ghadri JR, Stehli J, Kazakauskaite E, et al. Cadmium-zinc-telluride myocardial perfusion imaging in obese patients. J Nucl Med 2012;53:1401-6.CrossRef Fiechter M, Gebhard C, Fuchs TA, Ghadri JR, Stehli J, Kazakauskaite E, et al. Cadmium-zinc-telluride myocardial perfusion imaging in obese patients. J Nucl Med 2012;53:1401-6.CrossRef
12.
Zurück zum Zitat Takahashi M, Miyazaki Y, Kondo A, Ehara T, Koga K, Matsunari I. Performance evaluation of the discovery NM/CT 670 CZT. J Nucl Med 2018;59:1835. Takahashi M, Miyazaki Y, Kondo A, Ehara T, Koga K, Matsunari I. Performance evaluation of the discovery NM/CT 670 CZT. J Nucl Med 2018;59:1835.
14.
Zurück zum Zitat Nakazato R, Berman DS, Hayes SW, Fish M, Padgett R, Xu Y, et al. Myocardial perfusion imaging with a solid-state camera: Simulation of a very low dose imaging protocol. J Nucl Med 2013;54:373-9.CrossRef Nakazato R, Berman DS, Hayes SW, Fish M, Padgett R, Xu Y, et al. Myocardial perfusion imaging with a solid-state camera: Simulation of a very low dose imaging protocol. J Nucl Med 2013;54:373-9.CrossRef
15.
Zurück zum Zitat Einstein AJ, Johnson LL, DeLuca AJ, Kontak AC, Groves DW, Stant J, et al. Radiation dose and prognosis of ultra-low-dose stress-first myocardial perfusion SPECT in patients with chest pain using a high-efficiency camera. J Nucl Med 2015;56:545-51.CrossRef Einstein AJ, Johnson LL, DeLuca AJ, Kontak AC, Groves DW, Stant J, et al. Radiation dose and prognosis of ultra-low-dose stress-first myocardial perfusion SPECT in patients with chest pain using a high-efficiency camera. J Nucl Med 2015;56:545-51.CrossRef
16.
Zurück zum Zitat Schepis T, Gaemperli O, Koepfli P, Rüegg C, Burger C, Leschka S, et al. Use of coronary calcium score scans from stand-alone multislice computed tomography for attenuation correction of myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging 2007;34:11-9.CrossRef Schepis T, Gaemperli O, Koepfli P, Rüegg C, Burger C, Leschka S, et al. Use of coronary calcium score scans from stand-alone multislice computed tomography for attenuation correction of myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging 2007;34:11-9.CrossRef
17.
Zurück zum Zitat Isgum I, de Vos BD, Wolterink JM, Dey D, Berman DS, Rubeaux M, et al. Automatic determination of cardiovascular risk by CT attenuation correction maps in Rb-82 PET/CT. J Nucl Cardiol 2017;25:2133-42.CrossRef Isgum I, de Vos BD, Wolterink JM, Dey D, Berman DS, Rubeaux M, et al. Automatic determination of cardiovascular risk by CT attenuation correction maps in Rb-82 PET/CT. J Nucl Cardiol 2017;25:2133-42.CrossRef
18.
Zurück zum Zitat Patchett ND, Pawar S, Miller EJ. Visual identification of coronary calcifications on attenuation correction CT improves diagnostic accuracy of SPECT/CT myocardial perfusion imaging. J Nucl Cardiol 2016;24:711-20.CrossRef Patchett ND, Pawar S, Miller EJ. Visual identification of coronary calcifications on attenuation correction CT improves diagnostic accuracy of SPECT/CT myocardial perfusion imaging. J Nucl Cardiol 2016;24:711-20.CrossRef
Metadaten
Titel
Do we need dedicated cardiac SPECT systems?
verfasst von
Piotr Slomka
Publikationsdatum
24.10.2019
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 4/2021
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-019-01921-7

Weitere Artikel der Ausgabe 4/2021

Journal of Nuclear Cardiology 4/2021 Zur Ausgabe

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

LDL-Cholesterin kann ApoB als Risikomarker nicht ersetzen

16.05.2024 Hypercholesterinämie Nachrichten

Apolipoprotein B (ApoB) ist ein genauer Risikomarker für atherosklerotisch bedingte Erkrankungen. Aber das LDL-Cholesterin doch auch – lohnt sich also die ApoB-Messung überhaupt?

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.